Cover storyFDA’s Proposed DTC Rule Could End TV Drug Ads
FDA’s Proposed DTC Rule would remove the adequate provision option for broadcast drug ads, requiring full risk information in every spot. See what pharma leaders can do now.
Cover storyFDA’s Proposed DTC Rule would remove the adequate provision option for broadcast drug ads, requiring full risk information in every spot. See what pharma leaders can do now.

FDA draft guidance FDA-2025-D-3217 defines acceptable Bayesian methodology use for primary inference in NDA, BLA, and IND clinical trial submissions.

FDA grants neladalkib accelerated approval for ALK-positive NSCLC, triggering confirmatory trial and manufacturing scale-up obligations for Nuvalent.

FDA approves Lembaz for infantile-onset NPC using external control survival data, setting a precedent for rare disease regulatory strategy.
Viatris completes Pacira BioSciences acquisition, adding EXPAREL and iovera° and triggering NDA transfer and manufacturing integration work.
Latest edition
SPONSORED
SPONSORED
SPONSORED
Nov 23
Nov 28From native content to event partnerships, we help brands earn the attention of a hard-to-reach, senior audience — without breaking the reading experience.
See partnership options →Explore expert-led guides crafted for pharma professionals. Log in to download and stay ahead.








Join thousands of pharma professionals getting our sharpest reporting, briefings and guides — free.

